The most recent and sophisticated multi-component transfection reagent, FuGENE ® 4K, was created to transfer DNA into both difficult and routine mammalian cell lines. Users are able to obtain higher ...

A Few Key Considerations Are Essential to Obtain the Best Return from Cell-Based Experiments Because optimal DNA delivery into mammalian cells depends on multiple factors, we recommend optimizing ...

LONDON--(BUSINESS WIRE)--Technavio has been monitoring the global transfection reagents and equipment market and the market is poised to grow by USD 319.58 million during 2020-2024 at a CAGR of over 6 ...

A novel cationic nanotechnology called jetOPTIMUS ® was created to increase the effectiveness of DNA transfection in adherent cells, including difficult-to-transfect cells. Transfection with ...

Gene therapy involves the transfer of genetically modified materials into a patient's cells to correct abnormal genes associated with diseases (Sun, 2017). Recent advancements in gene therapy have ...

Researchers and companies are devising promising approaches to circumvent limitations of existing transfection technologies. Ongoing challenges, particularly with regard to high-quality recombinant ...

Transfection alters the genetic makeup of eukaryotic cells by introducing foreign nucleic acids, including DNA, RNA, and small noncoding RNAs such as siRNA, shRNA, and miRNA. Scientists use ...

Six years ago, when John Tinsley's postdoctoral advisor at Texas A&Mtold him to find a protocol to introduce proteins into coronary endothelial cells, he couldn't find one in the literature. Tinsley ...

MADISON, Wis., Aug. 11, 2021 /PRNewswire/ -- Mirus Bio, an innovator in transfection technologies, today announces the launch of the TransIT® VirusGEN® GMP product line. This expansion to the existing ...

New York, June 18, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Non-Viral Transfection Reagents and Systems Market, 2020-2030 ...